Evolution of Cortical and White Matter Lesion Load in Early-Stage Multiple Sclerosis: Correlation With Neuroaxonal Damage and Clinical Changes
- PMID: 33013644
- PMCID: PMC7498574
- DOI: 10.3389/fneur.2020.00973
Evolution of Cortical and White Matter Lesion Load in Early-Stage Multiple Sclerosis: Correlation With Neuroaxonal Damage and Clinical Changes
Abstract
Introduction: Changes in cortical and white matter lesion (CL, WML) load are pivotal metrics to diagnose and monitor multiple sclerosis patients. Yet, the relationship between (i) changes in CL/WML load and disease progression and between (ii) changes in CL/WML load and neurodegeneration at early MS stages is not yet established. In this work, we have assessed the hypothesis that the combined CL and WML load as well as their 2-years evolution are surrogate markers of neurodegeneration and clinical progression at early MS stages. To achieve this goal, we have studied a group of RRMS patients and have investigated the impact of both CL and WML load on neuroaxonal damage as measured by serum neurofilament light chain (sNfL). Next, we have explored whether changes in CL/WML load over 2 years in the same cohort of early-MS are related to motor and cognitive changes. Methods: Thirty-two RRMS patients (<5 years disease duration) underwent: (i) 3T MRI for CL/WML detection and clinical assessment at baseline and 2-years follow-up; and (ii) baseline blood test for sNfL. The correlation between the number and volume of CL/WML and sNfL was assessed by using the Spearman's rank correlation coefficient and a generalized linear model (GLM). A GLM was also used to assess the relationship between (i) the number/volume of new, enlarged, resolved, shrunken, stable lesions and (ii) the difference in clinical scores between two time-points. Results: At baseline, sNfL levels correlated with both total CL count/volume (ρ = 0.6/0.7, Corr-P <0.017/Corr-P < 0.001) and with total WML count/volume (ρ = 0.6/0.6, Corr-P < 0.01 for both). Baseline sNfL levels also correlated with new WML count/volume (ρ = 0.6/0.5, Corr-P < 0.01/Corr-P < 0.05) but not with new CL. Longitudinal changes in CL and WML count and volume were significantly associated with (i) sustained attention, auditory information, processing speed and flexibility (p < 0.01), (ii) verbal memory (p < 0.01); (iii) verbal fluency (p < 0.05); and (iv) hand-motor function (p < 0.05). Discussion: Changes in cortical and white matter focal damage in early MS patients correlate with global neuroaxonal damage and is associated to cognitive performances.
Keywords: MP2RAGE; MRI; cortical lesions; early relapsing remitting multiple sclerosis; serum neurofilamants.
Copyright © 2020 Todea, Lu, Fartaria, Bonnier, Du Pasquier, Krueger, Bach Cuadra, Psychogios, Kappos, Kuhle and Granziera.
Figures



Similar articles
-
Cortical lesions uniquely predict motor disability accrual and form rarely in the absence of new white matter lesions in multiple sclerosis.medRxiv [Preprint]. 2023 Sep 25:2023.09.22.23295974. doi: 10.1101/2023.09.22.23295974. medRxiv. 2023. PMID: 37886541 Free PMC article. Preprint.
-
MP2RAGE provides new clinically-compatible correlates of mild cognitive deficits in relapsing-remitting multiple sclerosis.J Neurol. 2014 Aug;261(8):1606-13. doi: 10.1007/s00415-014-7398-4. Epub 2014 Jun 10. J Neurol. 2014. PMID: 24912471
-
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.Mult Scler. 2019 Apr;25(5):678-686. doi: 10.1177/1352458518765666. Epub 2018 Mar 15. Mult Scler. 2019. PMID: 29542376
-
Mitoxantrone: a review of its use in multiple sclerosis.CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010. CNS Drugs. 2004. PMID: 15089110 Review.
-
Disease biomarkers in multiple sclerosis: current serum neurofilament light chain perspectives.Neurodegener Dis Manag. 2021 Aug;11(4):329-340. doi: 10.2217/nmt-2020-0058. Epub 2021 Jul 1. Neurodegener Dis Manag. 2021. PMID: 34196596 Review.
Cited by
-
Predicting multiple sclerosis disease progression and outcomes with machine learning and MRI-based biomarkers: a review.J Neurol. 2024 Oct;271(10):6543-6572. doi: 10.1007/s00415-024-12651-3. Epub 2024 Sep 12. J Neurol. 2024. PMID: 39266777 Free PMC article. Review.
-
Mapping tissue microstructure across the human brain on a clinical scanner with soma and neurite density image metrics.Hum Brain Mapp. 2023 Sep;44(13):4792-4811. doi: 10.1002/hbm.26416. Epub 2023 Jul 17. Hum Brain Mapp. 2023. PMID: 37461286 Free PMC article.
-
Benefits of a mosaic approach for assessing cortical atrophy in individual multiple sclerosis patients.Brain Behav. 2023 Dec;13(12):e3327. doi: 10.1002/brb3.3327. Epub 2023 Nov 13. Brain Behav. 2023. PMID: 37961043 Free PMC article.
-
GAMER-MRI in Multiple Sclerosis Identifies the Diffusion-Based Microstructural Measures That Are Most Sensitive to Focal Damage: A Deep-Learning-Based Analysis and Clinico-Biological Validation.Front Neurosci. 2021 Apr 6;15:647535. doi: 10.3389/fnins.2021.647535. eCollection 2021. Front Neurosci. 2021. PMID: 33889069 Free PMC article.
-
The Pig as a Translational Animal Model for Biobehavioral and Neurotrauma Research.Biomedicines. 2023 Aug 1;11(8):2165. doi: 10.3390/biomedicines11082165. Biomedicines. 2023. PMID: 37626662 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources